Article

Dems Tout Impact of Reform Law Drug Program

Congressional Democrats heralded a new Government Accountability Office report (PDF) as proof that the Patient Protection and Affordable Care Act's discount prescription drug program is working as planned.

Starting in January 2011, the law stipulated that drugmakers that want their products covered under Medicare Part D must participate in the drug discount program. Under this provision, the drug manufacturers must provide a 50% discount on the price that Part D plan sponsors negotiate for brand-name drugs when beneficiaries reach the so-called doughnut hole—the gap between the initial and catastrophic coverage periods where Medicare helps pay the costs.

Read the full story: http://tinyurl.com/8n432mf

Source: Modern Healthcare

Related Videos
Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital
Io Hui, PhD, researcher at The University of Edinburgh
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel
Adam Colborn, JD, of AMCP
Corey McEwen, PharmD, MS
Daniel Howell, MBBS
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo